Outliers: The FDA follows the EMA [BE/BA News]

posted by jag009  – NJ, 2019-03-06 20:23 (2660 d 07:52 ago) – Posting: # 20002
Views: 4,846

Hi Helmut,

So they effectively killed off the re-dose/re-challenge study then?
I spoke to a colleague earlier this year and he said FDA no longer wants to see re-challenge study...

John

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
166 visitors (0 registered, 166 guests [including 17 identified bots]).
Forum time: 05:15 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5